Gini AI

Heart Rate Variability

Continuous clinical-grade ECG monitoring with AI anomaly detection.

Skin Temperature

High-precision thermal sensors detecting micro-fluctuations in body heat.

Sleep Architecture

Deep sleep stage analysis and recovery optimization algorithms.

Blood Oxygen (SpO2)

Advanced optical sensors for continuous nighttime and daytime oxygen tracking.

AI Synthesis

Sensecore AI Lab Limited's proprietary neural network synthesizes data into actionable health insights.

Real-time Alerts

Predictive algorithms notify you of potential health deviations before they escalate.

Gini AI is an ultra-miniaturized smart ring and integrated AI platform designed for continuous, passive monitoring of physiological and behavioral biomarkers. Unlike episodic clinical assessments, Gini AI establishes a high-resolution "biometric baseline" for users, tracking subtle shifts in circadian rhythms, sleep architecture, Heart Rate Variability (HRV), and spontaneous activity levels — all of which are early indicators of neurodegenerative decline.

Current dementia diagnosis often relies on late-stage cognitive decline noticeable to family members. Gini AI identifies "digital biomarkers" of prodromal dementia — the stage before clear symptoms appear. By flagging deviations in nighttime restlessness and autonomic nervous system dysfunction, the system prompts earlier GP referrals, contributing to the NHS target of 92% of patients receiving a diagnosis within 18 weeks.

Post-diagnosis, Gini AI acts as a 24/7 clinical monitor. It detects "micro-changes" in health — such as increased nocturnal wandering or decreased daytime social mobility — which often precede a major clinical crisis. This allows for proactive intervention, medication adjustments, and personalised care planning, keeping patients in their homes longer and reducing emergency hospital admissions.

Built with DTAC and UK-GDPR compliance at its core, the Gini AI ecosystem is designed for seamless integration into NHS Single Patient Records. Our roadmap targets full UKCA medical device certification by 2028, ensuring the Gini Ring is a validated, "prescribable" tool ready for nationwide deployment by 2029.